Endovascular implantation of 125I seed combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The purpose of this study was to evaluate the efficacy and safety of the endovascular implantation of 125I seed under ultrasound and x-ray guidance combined with transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Future Oncol

Title: Future oncology (London, England)

Publisher: Future Medicine Ltd

ISSN (Electronic): 1744-8301

ISSN (Print): 1479-6694

Publication date (Electronic): May 2018

Volume: 14

Issue: 12

Affiliations

[1 ] Department of Interventional Radiology, The Cancer Hospital of Harbin Medical University, Harbin, 150040, PR China.

[2 ] Department of Medical Oncology, The Cancer Hospital of Harbin Medical University, Harbin, 150040, PR China.

[3 ] Department of Imaging & Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, PR China.

Article

DOI: 10.2217/fon-2017-0354

PubMed ID: 29334777

SO-VID: 80a0b5e9-c026-42ad-8976-63999190bcf9

History

Keywords: hepatocellular carcinoma,125I seed,TACE,portal vein tumor thrombosis

Data availability:

Keywords: hepatocellular carcinoma, 125I seed, TACE, portal vein tumor thrombosis

Endovascular implantation of 125I seed combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.

Read this article at

Abstract

Related collections

Karger: Oncology

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 12